Khalid A, Pal R, Sasatomi E, Swalsky P, Slivka A, Whitcomb D, Finkelstein S
Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, M2 c-wing PUH, 200 Lothrop St, Pittsburgh, PA 15213, USA.
Gut. 2004 Dec;53(12):1860-5. doi: 10.1136/gut.2004.039784.
Brush cytology of biliary strictures to diagnose pancreaticobiliary malignancy suffers from poor sensitivity.
To improve the diagnostic yield of pancreaticobiliary brush cytology through analysis of tumour suppressor gene linked microsatellite marker loss of heterozygosity (LOH) and k-ras codon 12 mutation detection.
Twenty six patients with biliary strictures underwent endoscopic retrograde cholangiography with brush cytology. A panel of 12 polymorphic microsatellite markers linked to six tumour suppressor genes was developed. Genomic DNA from cell clusters acquired from brush cytology specimens and microdissected surgical malignant and normal tissue underwent polymerase chain amplification reaction (PCR). PCR products were compared for LOH and k-ras codon 12 mutations.
Seventeen patients were confirmed to have pancreaticobiliary adenocarcinoma. Nine patients had benign strictures (eight proven surgically, one by follow up). Cytomorphological interpretation was positive for malignancy (n = 8), indeterminate (n = 10), and negative for malignancy (n = 8). Selected malignant appearing cytological cell clusters and microdissected histological samples from cancer showed abundant LOH characteristic of malignancy while brushings from nine cases without cancer carried no LOH (p<0.001). LOH and k-ras mutations profile of the cytological specimens was almost always concordant with the tissue samples. Presence of k-ras mutation predicted malignancy of pancreatic origin (p<0.001).
LOH and k-ras codon 12 mutation analysis of PCR amplified DNA from biliary brush cytology discriminates reactive from malignant cells, with 100% sensitivity, specificity, and accuracy. Minor variations in LOH in brushings and in different sites within the same tumour likely reflect intratumoral mutational heterogeneity during clonal expansion of pre- and neoplastic lineages.
胆管狭窄的刷检细胞学用于诊断胰胆管恶性肿瘤时,敏感性较差。
通过分析与肿瘤抑制基因相关的微卫星标记杂合性缺失(LOH)及检测k-ras密码子12突变,提高胰胆管刷检细胞学的诊断率。
26例胆管狭窄患者接受了内镜逆行胆管造影及刷检细胞学检查。开发了一组与6个肿瘤抑制基因相关的12个多态性微卫星标记。从刷检细胞学标本获取的细胞团簇以及显微切割的手术切除恶性和正常组织的基因组DNA进行聚合酶链反应(PCR)。比较PCR产物的LOH及k-ras密码子12突变情况。
17例患者确诊为胰胆管腺癌。9例患者为良性狭窄(8例经手术证实,1例经随访证实)。细胞形态学诊断为恶性(n = 8)、不确定(n = 10)和非恶性(n = 8)。从恶性细胞学细胞团簇及癌组织显微切割的组织学样本中检测到大量具有恶性特征的LOH,而9例无癌病例的刷检样本未检测到LOH(p<0.001)。细胞学标本的LOH和k-ras突变谱几乎总是与组织样本一致。k-ras突变的存在提示胰腺来源的恶性肿瘤(p<0.001)。
对胆管刷检细胞学PCR扩增DNA进行LOH和k-ras密码子12突变分析可区分反应性细胞与恶性细胞,敏感性、特异性及准确性均为100%。刷检样本及同一肿瘤不同部位LOH的微小差异可能反映肿瘤前和肿瘤性谱系克隆扩增过程中的肿瘤内突变异质性。